Globex Sells Another Saskatchewan Alkali Disposition
April 15, 2024 10:37 ET
|
Globex Mining Enterprises Inc.
ROUYN-NORANDA, Quebec, April 15, 2024 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS...
Lithium Ionic Announces 26% Increase in Global Mineral Resources with an Updated Mineral Resource Estimate at its Bandeira Project, Minas Gerais, Brazil
April 12, 2024 09:55 ET
|
Lithium Ionic Corp.
Global Mineral Resources increase 26% to 60.1Mt: M&I: 32.51Mt grading 1.31% Li2OInferred: 27.57Mt grading 1.24% Li2O Updated Bandeira Mineral Resources of 41.9 Mt grading 1.35% Li2O M&I:...
OZANK Joins Forces with RevoluGROUP to Enhance Global Payment Infrastructure
April 11, 2024 14:32 ET
|
RevoluGROUP Canada Inc.
Vancouver, BC and Barcelona, Spain, April 11, 2024 (GLOBE NEWSWIRE) -- RevoluPAY EP S.L. (“RevoluPAY”), a wholly owned subsidiary of RevoluGROUP Canada Inc. (TSX-V: REVO), (Frankfurt: IJA2),...
Emperor Announces Final Results from 2023 Exploration Campaign and Strategic Insights for 2024 at the Duquesne West Gold Project
April 10, 2024 09:36 ET
|
Globex Mining Enterprises Inc.
ROUYN-NORANDA, Quebec, April 10, 2024 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS...
Basilea awarded CARB-X grant to develop recently acquired novel class of antibiotics
April 09, 2024 01:15 ET
|
Basilea Pharmaceutica AG
Allschwil, Switzerland, April 09, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial...
Basilea erhält CARB-X-Förderung für die Entwicklung einer kürzlich erworbenen neuen Antibiotika-Wirkstoffklasse
April 09, 2024 01:15 ET
|
Basilea Pharmaceutica AG
Allschwil, 09. April 2024 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel, Patienten zu helfen, die an schweren...
Lithium Ionic Announces Maiden Mineral Resource Estimate and Initiation of PEA at its Salinas Project, Minas Gerais, Brazil; Increases Regional Mineral Resources by 45%
April 04, 2024 14:14 ET
|
Lithium Ionic Corp.
Salinas MRE increases global resources by 45% to 47.8Mt M&I: 5.86Mt @ 1.09% Li2OInferred 8.9Mt @ 0.97% Li2O~65% of the MRE is considered open pit PEA for Salinas initiated; completion expected...
Basilea announces US FDA approval of antibiotic ZEVTERA® (ceftobiprole medocaril) for three indications
April 04, 2024 01:15 ET
|
Basilea Pharmaceutica AG
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, April 04, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to...
Basilea gibt Erhalt der US-FDA-Zulassung für Antibiotikum ZEVTERA® (Ceftobiprol-Medocaril) für drei Indikationen bekannt
April 04, 2024 01:15 ET
|
Basilea Pharmaceutica AG
Ad hoc-Mitteilung gemäss Art. 53 KR Allschwil, 04. April 2024 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel,...
NurExone Reports Fourth Quarter and Year Ended December 31, 2023 Financial Results and Provides Company Update
April 02, 2024 08:31 ET
|
NurExone Biologic Inc
NurExone Reports Fourth Quarter and Year Ended December 31, 2023 Financial Results and Provides Company Update